Status:
COMPLETED
Genomics of In-Stent Restenosis
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
In-Stent Restenosis
Vascular Disease
Eligibility:
All Genders
18+ years
Brief Summary
This study, conducted in Argentina at the Hospital Espa ol de la Plata and the Hospital Franc s de Buenos Aires, in collaboration with the NHLBI, will investigate possible genetic factors that lead to...
Detailed Description
Our laboratory is investigating the genetic basis of the vascular disease, in-stent restenosis. We hypothesize that patients with in-stent restenosis have abnormal expression of cell cycle regulatory ...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA
- Patients 18 years of age or older
- Patients undergoing coronary endarterectomy as part of their course of medical therapy. The lesion for which endarterectomy is being performed is restenosis within a bare metal stent within a native coronary artery
- EXCLUSION CRITERIA
- Current enrollment in a clinical trial for the treatment or prevention of in-stent restenosis.
- Lesion within saphenous vein graft following coronary artery bypass grafting
- Patients younger than 18 years of age
- The patient is unable to provide informed consent
Exclusion
Key Trial Info
Start Date :
September 1 2005
Trial Type :
OBSERVATIONAL
End Date :
July 1 2006
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00341562
Start Date
September 1 2005
End Date
July 1 2006
Last Update
March 4 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Heart, Lung and Blood Institute (NHLBI)
Bethesda, Maryland, United States, 20892